BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19256743)

  • 1. Effect of demographic and clinicopathologic factors on prognosis of early gastric cancer in Iran.
    Moghimi-Dehkordi B; Safaee A; Pourhoseingholi MA; Zali MR
    Asian Pac J Cancer Prev; 2008; 9(4):585-8. PubMed ID: 19256743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis and surgical treatment of gastric cancer invading adjacent organs.
    Zhang M; Zhang H; Ma Y; Zhu G; Xue Y
    ANZ J Surg; 2010; 80(7-8):510-4. PubMed ID: 20795964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariate analysis of prognostic factors in gastric cancer patients using additive hazards regression models.
    Maroufizadeh S; Hajizadeh E; Baghestani AR; Fatemi SR
    Asian Pac J Cancer Prev; 2011; 12(4):901-7. PubMed ID: 21790223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy predicts lymph node metastasis in early gastric cancer: a retrospective analysis.
    Dong LF; Wang LB; Shen JG; Xu CY
    Dig Surg; 2012; 29(2):124-9. PubMed ID: 22538386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery.
    Posteraro B; Persiani R; Dall'Armi V; Biondi A; Arzani D; Sicoli F; Bonassi S; D'Ugo D; Ricciardi W; Boccia S
    Eur J Surg Oncol; 2014 Mar; 40(3):345-51. PubMed ID: 24268760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes.
    Martinez-Ramos D; Calero A; Escrig-Sos J; Mingol F; Daroca-Jose JM; Sauri M; Arroyo A; Salvador-Sanchis JL; de Juan M; Calpena R; Lacueva FJ
    Eur J Surg Oncol; 2014 Mar; 40(3):358-65. PubMed ID: 24075824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKR1B10, a good prognostic indicator in gastric cancer.
    Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
    Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant prognostic factors in patients with early gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
    Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
    JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in gastric cancer using log-normal censored regression model.
    Pourhoseingholi MA; Moghimi-Dehkordi B; Safaee A; Hajizadeh E; Solhpour A; Zali MR
    Indian J Med Res; 2009 Mar; 129(3):262-7. PubMed ID: 19491418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in gastric cancer patients: univariate and multivariate analysis.
    Moghimi-Dehkordi B; Safaee A; Ghiasi S; Zali MR
    East Afr J Public Health; 2009 Apr; 6 Suppl(1):41-4. PubMed ID: 20084985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate analysis of prognostic factors in gastric cancer patients using additive hazards regression models.
    Maroufizadeh S; Hajizadeh E; Baghestani AR; Fatemi SR
    Asian Pac J Cancer Prev; 2011; 12(7):1697-702. PubMed ID: 22126547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of patient characteristics, prognosis, treatment modalities, and survival according to age group in gastric cancer patients.
    Tural D; Selçukbiricik F; Serdengeçti S; Büyükünal E
    World J Surg Oncol; 2012 Nov; 10():234. PubMed ID: 23121731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate prognostic study on large gastric cancer.
    Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
    J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic resection for synchronous hepatic metastasis from gastric cancer.
    Qiu JL; Deng MG; Li W; Zou RH; Li BK; Zheng Y; Lao XM; Zhou K; Yuan YF
    Eur J Surg Oncol; 2013 Jul; 39(7):694-700. PubMed ID: 23579173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.